Alirocumab Advancing Cardiovascular Health Through PCSK9 Inhibition Introduction Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide. Central to its pathogenesis is the accumulation of low-density lipoprotein cholesterol (LDL-C) in arterial walls, leading to atherosclerosis. While statins have long […]
Evolocumab A Breakthrough in Lipid-Lowering Therapy for Cardiovascular Risk Reduction Introduction Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality globally. Elevated low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for atherosclerosis and coronary artery disease. While statins have […]